Study to Investigate the Mechanism of Action of an Oral Enzyme Treatment With Bromelain, Trypsin and Rutoside Versus Placebo in Subjects With OsTeoarthritis
Clinical trial NCT05038410 · COMPLETED
Trial details
- NCT number
- NCT05038410
- Sponsor
- Mucos Pharma GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-30
- Primary completion
- 2022-10-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.